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CLINICAL INVESTIGATION
Renal excretion and cyst accumulation of /32microglobulin in
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Renal excretion and cyst accumulation of 2microglobulin in polycystic
kidney disease. To determine the extent to which proximal tubule
function is altered /32microglobulin (/32m), creatinine and Na were
measured in serum, urine and cyst fluid of patients with autosomal
dominant polycystic kidney disease and various degrees of renal
insufficiency. Fractional excretion (FEm) was 0.11 0.03% in six
normal subjects and 0.13 0.05% in nine patients with serum creati-
nine levels less than 1.6 nig/dI. In five patients with serum creatinine
levels above 3.0 mgldl, FEm was elevated (range 3.5 to 196%) and
serum levels were higher than normal (30,600 6,910 sg/liter vs.
1,268 Ill). In seven patients /32m levels in 33 proximal cysts(cyst/serum Na > 0.8) equalled those in serum (cyst/serum 132m
0.98 0.20), whereas in 21 distal cysts (cyst/serum Na < 0.4) f32m was
less than in serum (cyst/serum /32m 0.17 0.07). Analysis of fluid in
two patients with polycystic kidney nephrectomy several weeks post-
transplant indicated that proximal cyst epithelium is permeable to f32m,
but less so than to creatinine or urea. These studies show that proximal
cysts cannot develop or maintain gradients for l3im, whereas distal
cysts maintain low levels of the protein despite end—stage renal failure.
The normal FEp2m values in nonazotemic autosomal dominant polycys-
tic kidney disease patients and the low distal cyst levels of f32m in
end—stage kidneys indicate that the cystic proximal nephrons do not
contribute appreciably to the final urine. These findings are consistent
with the view that a relatively small number of cystic tubules ultimately
compromise the function of non-cystic nephrons.
Autosomal dominant polycystic kidney disease (ADPKD) is a
common heritable renal disorder in which the kidneys progres-
sively enlarge as normal parenchyma is replaced by innumera-
ble fluid—filled cysts [1—3]. Microdissection of acid—hydrolyzed
nephron segments and analysis of the chemical composition of
cyst fluid from kidneys of patients with ADPKD indicate that
the cysts are derived from and may remain connected to renal
tubules 14—6]. The cyst epithelium appears to function, even in
"end stage" kidneys, in several ways similar to the nephron
segments from which the cysts derive. The intercellular junc-
tions are permeable to lanthanum, and transepithelial gradients
of Na, K and osmolality are not effectively maintained by
"proximal" cysts [7]. By contrast, "distal" cysts are lined by
cells with tight junctions that restrict the movement of the
lanthanum tracer; this allows for the long—term maintenance of
relatively steep transepithelial gradients of creatinine, hydrogen
ion, sodium and potassium [7—9]. Recent direct studies of cyst
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walls in vitro have confirmed the ability of certain cysts to
actively transport solutes [10].
/32microglobulin (/32m) is a normal plasma protein that is
produced by a variety of cells in the body, filtered by glomeruli
and extensively reabsorbed by the proximal tubules. In the
course of reabsorption the proximal tubule cells metabolize f32m
to the constituent amino acids that are returned, in part, to the
plasma [11]. The fractional excretion of /32m in normal subjects
is less than 1% of the filtered load [11, 12], Thus, the plasma
level of f32m is primarily dependent on the rate of production
and glomerular filtration, whereas the urinary excretion rate
depends on the rate of /32m filtration by glomeruli and the extent
to which the protein is absorbed and metabolized by proximal
tubule cells.
/32m is present in serum, urine, CSF, saliva and other
biological fluids primarily as a free monomer [13—15]. Because
of its size (11,600 Daltons, Stoke's radius 1.6 nm) it is reason-
able to expect that this solute is filtered by glomeruli of
polycystic kidneys and that the concentration of /32m in renal
cysts reflects the capacity of the afferent tubular epithelium and
the cyst epithelium to transport and metabolize /32m. In the
present study we determined 2m levels in cyst fluid, serum and
urine of patients with ADPKD to evaluate the utility of this
unique protein as an additional marker of renal tubule and cyst
function.
Methods
We studied two distinct sets of patients with ADPKD.
Fourteen ambulatory patients were followed in the ADPKD
clinic at the University of Kansas Medical Center; eight other
patients and one ambulatory patient (D.S.) had one or both
polycystic kidneys surgically removed. Consent was obtained
for the collection of serum, cyst fluid and urine specimens.
Renal excretion of f32m
Blood and mid-stream urine samples were collected between
8 a.m. and 1 p.m. from 14 ambulatory patients with ADPKD
(seven females and seven males) and six normal persons (three
females and three males). The normal subjects had no detect-
able renal disease and no family history of renal disease. Serum
and urine specimens from each subject were collected concur-
rently and refrigerated immediately. Twenty-four hour urine
samples were not consistently available. Blood samples were
centrifuged the day of collection. Serum and urine samples
were tightly sealed and stored at —20°C.
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Distribution of f32m in kidney cysts
We obtained clear fluid from superficial (subcapsular) cysts
and serum from nine patients (five females and four males) with
ADPKD. Eight of these patients are described and detailed
methods of sample collection are outlined in Huseman et al [9].
Patient D.S. was added to the previous group and samples were
processed identically. All sealed specimens were stored at
—20°C in tightly—capped glass vials. One patient was non-
azotemic (T.H.), the kidneys having been donated ostensibly
for cadaveric renal transplantation. Two patients had received
kidney transplants and had their cystic kidneys removed six
(A.B.) and 12 weeks (M.G.) post-transplant because of intrac-
table renal infection. Both of these patients had serum creati-
nine levels below 2.0 mg/dl within one week post-transplant.
Serum samples were obtained prior to and following cadaveric
renal transplantation. Patient A.B's serum, drawn at the time of
nephrectomy, was not available for 132m assay. As the patient
has a normally functioning renal allograft, a recent serum
sample was used for J32m determination. The remaining five
patients were treated with thrice—weekly chronic hemodialysis
using hollow—fiber or parallel plate dialyzers. In these patients,
nephrectomies were performed for intractable infection, pain or
in preparation for renal transplantation.
Analysis of data and calculations
Sodium and creatinine in serum, cyst fluid and urine were
measured in the University of Kansas Clinical Pathology Lab-
oratories by an Autoanalyzer technique. By convention "prox-
imal" cysts have cyst/serum Na ratios > 0.8, and "distal" cysts
have ratios <0,4 [9]. f32m was determined in serum, cyst fluid
and urine with the Phadezym f32micro Test kit, a competitive
immunoassay method obtained from Pharmacia Diagnostics of
Sweden. In this assay, a known amount of enzyme—labelled
/32m competes with pm in each sample for binding sites on a
Sephadex anti-/32m complex. The enzyme, Sephadex and an
aliquot of serum, urine or cyst fluid were incubated together for
one hour at 37°C. Each sample and five different concentrations
of standard were run in duplicate. Bound and free /32m were
separated by centrifugation. A reducing agent and substrate
supplied by the manufacturer were added to the solution to
release and then hydrolyze the enzyme during a one hour
incubation at 37°C. The product was yellow with an absorbance
maximum of 420 nm. Hydrolysis was terminated by addition of
the manufacturer's Stop solution.
Absorbance levels measured at 420 nm with a Gilford Stasar
III spectrophotometer were inversely proportional to the con-
centration of 2m in the sample. A linear standard curve ranging
from 10 to 500 pg/liter /32m concentration was constructed for
each assay. Results of all unknowns were determined by
interpolation between standards and expressed in pg/liter after
correction for the dilution factor. f32m levels were considered
undetectable if absorbance readings were higher than 0.830 in
undiluted samples; the lower limit of detection was 10 tg/liter.
Serum, cyst fluid and urine were generally diluted 1:50 to 1:200,
1:5 to 1:200, and 1:5 to 1:200 with buffer, respectively. j32m
recovery in normal serum and urine was 72 and 77%, respec-
tively.
To evaluate reproducibility of the assay, we collected 10 mls
of serum from a normal subject and separated it into 200 l
aliquots that were frozen. An aliquot was run in duplicate along
with each assay to assess reproducibility from day to day. Each
serum aliquot was used for one assay and then discarded. In 14
separate assays covering four months, the mean absorbance of
this serum (± SD) was 0,644 0.094. The calculated 132m
concentration of the serum (mean SD) was 1610 568
tg/liter. The lower coefficient of variation of the absorbance
values (14.6%) compared to the final /32m concentrations
(35.3%) probably reflects variation among the different f32m
standards supplied with the individual assay kits. To minimize
the impact of this variability for the critical comparisons be-
tween proximal and distal cyst fluids, serum and urine samples
for a given subject were run on the same day. Consequently,
intra-subject comparisons had less inherent methodologic vari-
ability than inter-subject comparisons.
Five separate collections of serum from an ADPKD patient
spanning a 2-1/2 year period of hemodialysis were assayed
concurrently. The measurements were repeated one month
later to determine the effect of storage. The mean f32m concen-
tration of the five separate serum samples was 31,300 3230
pjg/liter (SD). The mean ratio of individual samples assayed one
month later was not significantly different from 1.0
(0.954 0.028, SE). The /32m concentrations for one of this
patient's proximal cysts assayed in duplicate one month apart
was 29,600 and 32,500 pg/liter, respectively. These measure-
ments indicate that serum 2m levels are relatively constant in
dialysis patients, and that serum and cyst fluid can be stored
frozen without an appreciable change in /32m levels.
Other workers have reported that 132m activity is decreased in
strongly acid urine [14, 16]. We obtained urine from a normal
subject and added HC1 or NaOH to separate 2 ml aliquots of the
urine to give four different samples with pH ranging from 4.3 to
7.5. f32m levels were assayed in duplicate on the same day the
samples were prepared. /32m concentrations of 1120, 725, 1090,
and 1040 g/liter for pH values of 4.3, 5.3, 6.2, and 7.5,
respectively, revealed no consistent effect of urine pH on the
f32m levels.
To determine the effect of pH on /32m levels in cyst fluid, we
utilized one of the samples with the highest /32m levels. To a 2
ml aliquot of this fluid sufficient isotonic HC1 was added to
reduce the pH to 5.0. An equal volume of isotonic Ringer's
bicarbonate solution was added to a second 2 ml aliquot of the
distal cyst fluid. Both samples were frozen immediately and
retrieved three weeks later. /32m was measured in triplicate and
pH was estimated by indicator paper. The mean 2m levels of
19,800 301 and 22,200 1490 tg/liter (SE) for pH 5.0 and 8.0
were not statistically different. These studies indicate that /32m
levels are stable in frozen urine and cyst fluid and relatively
insensitive to pH values between 4.3 and 8.0.
Since cyst fluids may contain a variety of plasma proteins [4,
8], we used high performance liquid chromatography (HPLC)
and proximal cyst fluid to separate the macromolecules [17].
HPLC was performed with a VISTA series 5500 (Varion Co.,
Walnut Creek, California, USA) using a TSKG 3000 SW
column. The elution buffer was 0.05 M Na2PO4 at pH 7.0 in 0.15
M NaCL. Absorbance was measured at 230 nm. Undiluted cyst
fluid (40 d) was injected into the column and effluent aliquots
were collected at one and one—half minute intervals. f32m levels
and absorbance were determined in each fraction (Fig. 1). Most
of the proteins in the cyst fluid had molecular weights> 12,000
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Table 1. Renal excretion of f32m
Subject Sex
Age
years
Creatinine
serum
mgldl
f32m
serum
pg/liter
f32m
urine
,ug/g creat. FEm
Normal
F
2 F
3 M
4 M
5 M
6 F
Mean SE
30
38
28
48
38
29
0.6
0.7
0.7
0.9
0.9
1.0
0.8 .06
1130
1180
1120
1150
1210
1820
1268 111
90
247
131
273
155
279
196 33
0.00048
0.00147
0.00082
0.00213
0.00012
0.00153
0.00109 0.00031
Non-azotemic ADPKD
55
37
29
56
39
50
35
40
61
0.8
0.9
0.9
0.9
1.1
1.1
1.3
1.6
1.6
1.1 0.1
1350
1190
2510
3225
4250
3080
5850
3840
5950
3472 570
243
99
55
191
275
234
2411
196
230
437 248
0.00144
0.00075
0.00020
0.00055
0.00071
0.00083
0.00535
0.00082
0.00062
0.00125 0.00052
WD F
SW F
AA F
SO F
CR M
PN M
TW M
DC M
MV F
Mean SE
Azotemic ADPKD
ME F
YS M
DS M
NC M
MA F
Mean SE
52
48
48
52
46
3.9
5.8
14.0
14.0
15.0
10.5 2.3
12700
17800
31900
49600
41000
30600 6910
55980
10770
65800
190900
535000
171700 95600
0.17200
0.03500
0.28900
0.53800
1.96000
0.5988 0.3500
a Hemodialysis 3 x week; M, Male; F, Female
daltons. The peak concentration of /32m coincided with a minor
protein fraction in the 12,000 molecular weight range, indicating
that the immuno-assay could discriminate between /32m and
other proteins in cyst fluid.
Apparent fractional delivery of /32m (FD) was calculated for
each cyst from 132m and creatinine concentrations using the
equation:
Equation 1: FD2m =
cyst creatinine/serum creatinine
Fractional excretion of f32m in the urine (FEim) was calcu-
lated using the equation:
Equation 2: FEp2m =
urine f32m/serum 2m
Results
Renal handling of f32m
In six normal adults (three female, three males) FE1m
averaged 0.0011 0.0003 with a mean /32m serum level of
1268 111 pg/liter (Table 1, Figs. 2, 3). The highest serum
creatinine level in the normal group was 1.0 mg/dl. In nine (five
females, four males) non-azotemic ADPKD patients FEjm
averaged 0.00125 0.00052, which is not significantly different
from the normal subjects (Table 1, Fig. 3). The serum creatinine
1,500
E
1,000
0.128
cyst thm/serum /32m
0.096
2,500
2,000
E
I
0.064
urine creatinine/serum creatinine
10 20
0.032
500
0
Fraction
Fig. 1. HPLC analysis of proximal cyst fluid molecular weighs. 40 1.d of
cyst fluid was injected and fractions collected every 1.5 minutes.
Dashed line shows /32m concentration and solid line light absorbance
due to protein. Molecular weight decreases from left to right. The major
f32m peak coincides with 12,000 Daltons. Major absorbance peaks to the
left represent globulins and albumin.
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levels exceeded those in the normals, the highest being 1.6
mgldl. The serum /32m levels (mean SE) of the non-azotemic
patients were also higher than the normals, 3472 570 Wliter,
P < 0.05, The rate of urinary 132m excretion, judged from the
urinary f32m/creatinine ratio, was not different between the
normal subjects and the non-azotemic ADPKD patients (Table
1)
In contrast to the non-azotemic ADPKD patients, those with
moderate to severe decreases in GFR, as judged by serum
creatinine levels exceeding 3.0 mg/dl, showed clear abnormal-
ities in /32m excretion (Table 1, Fig. 2). In two azotemic
non-dialysis patients the serum levels of f32m exceeded 10,000
pg/liter, FEp2m was greater than 0.035 and the urinary excretion
rate of f32m was over 10,000 g!g creatinine. In the azotemic
hemodialysis patients the serum /32m levels exceeded 30,000
g/1iter, FEm was over 0.289 and the urinary excretion rate
exceeded 65,000 g/g creatinine.
Cyst levels of f32m
We measured 2m levels in fluids aspirated from 33 proximal
and 21 distal cysts in seven patients with ADPKD; one was
non-azotemic (T.H.) and six were regularly hemodialyzed (Ta-
ble 2). The relative numbers of proximal and distal cyst fluid
samples do not reflect the proportion of these types of cysts in
ADPKD subjects [9]; rather the samples reflect the availability
of adequate volumes of fluid in each subject. With the exception
of D. S., all ADPKD patients were included in an earlier report
[9].
The average cyst/serum ratio of 132m in proximal cysts from
six dialysis patients and T.H. was 0.985 0.202, which is not
different from 1.0 (Table 2). The range of ratios was wide,
however, extending from 0.409 to 1.754. By contrast, the mean
cyst/serum /32m ratio in distal cysts was 0.171 0.068 which is
statistically lower (P < 0.01) than the proximal ratios. In distal
cysts the ratios ranged from 0 to 0.467. Of the 21 distal cysts, 11
had no detectable /32m. By contrast, f32m was not detected in
only one of 33 proximal cysts. In T.H., the non-azotemic
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Fig. 2. Relation between serum creatinine and $2m levels in normal and
ADPKD subjects. Dialysis patients had creatinine values between 8.5
and 15 mgldl. Symbols are: (E) non-dialysis PKD; (5) dialysis PKD;
and (X) normal.
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Fig. 3. Relation between serum creatinine level and FE2, in normal
and ADPKD subjects. Same subjects as Figure 2 except for four
dialysis patients from whom urine samples could not be obtained.
Symbols are the same as Figure 2.
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Table 2. Cyst concentrations of /32M and creatininea
kidney donor, only one distal cyst fluid sample was available for
assay and the /32m level was lower than in any of the five
proximal cysts assayed from this kidney.
In two patients (A.B. and M.G.) the cyst fluid samples were
obtained after restoration of normal serum creatinine and urea
levels following renal transplantation. In M.G. no distal cysts
were available for assay. In A.B. the f32m levels in the proximal
cysts were higher than in the distal cysts (Table 2).
The mean /32m values for all subjects in this study were
uniformly lower in distal in comparison to proximal cysts (Fig.
4A). Moreover, the apparent fractional delivery of /32m (FD2m),
utilizing creatinine as the reference marker of glomerular filtra-
Age
Serum Proximal cysts Distal cysts
Creatinine /32m Creatinine /32m Creatinine /32m
Patient Sex years mg/dl ,aglliter mgldl sag/liter FDm mg/dl pg/liter FD13m
Dialysis
PB
RC
MW
DS
TB
JS
Kidney Donor
TH
Post-transplant
AB
MG
8.0 24,500 1.55 29.0 69 0.002
7.0 20,600 1.40
8.0 19,600 1.24
7.0 8,500 0.62
F 64 11.1 36,800 7.5
9.0
7.5
8.5
8.5
18,000
16,100
19,700
21,500
0
0.72
0.54
0.79
0.76
0
39.0
64.0
0
0
0
0
F 47 11.5 20,200 10.0
9.5
9.5
9.5
10.0
11.0
24,500
18,100
28,600
32,200
37,600
33,300
1.39
1.08
1.70
1.91
2.14
1.72
6.0
106.0
38.0
57
54
0
0.005
0.003
0
M 48 12.0 42,500 9.6
14.8
14.8
19,100
30,000
30,000
0.56
0.57
0.41
35.0 11,200 0.090
M 46 12.8 19,400 10.0
10.0
11.0
10.0
10.0
23,400
4,350
12,700
12,000
4,000
1.55
0.29
0.76
0.79
0.26
86.0
106.0
38.0
16,700
54
0
0.128
0.0003
0
M 48 15.3 6,550 13.9
13.0
13.9
116.0
9,450
9,750
17,500
105
1.58
1.75
2.93
0.002
8.0
15.5
13.9
9.5
23.0
67.0
24.5
21.6
91.9
0
0
0
43
0
0
0
0
0
0
0
0
0.011
0
0
0
0
0
F 34 1.13 1,510 0.7
0.7
0.5
0.7
1.0
1,170
1,570
1,110
970
875
1.44
1.93
1.91
1.19
0.75
7.4 268 0.031
M 36 1.4 3,830 1.4
1.5
1.4
1.3
1.2
9,300b
8,300
8,800
6,500
8,500
41.0
93.9
105.0
101.0
13.0
540"
297
297
32
0
F 43 1,7 5,400 1.5
1.5
2.0
1.5
1.5
8,2501
8,550
9,450
15,000
11,000
a Zero values reflect 132m levels below the limits of detectionb FD values not calculated since cyst concentration not at steady state
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0
Distal
Fig. 4. Cyst fluid f32m levels. A. Mean /32m levels in dialysis and
non-dialysis patients. One of the non-dialysis patients was never
azotemic and two of them were not azotemic following renal transplan-
tation. Lines connect mean "proximal" and "distal" f32m values in
each subject. One patient had no distal samples. B. Mean fractional
delivery values for /32m (FDp2m) in same subjects shown in A. Symbols
are: (•) dialysis; and non-dialysis (La) non-azotemic and (A)
post-transplant.
tion, was also uniformly lower than in each of the proximal
cysts (Fig. 4B). As will be discussed later, creatinine is not an
ideal filtration marker as it penetrates proximal cyst epithelium.
Distal cysts, however, are sparingly permeable to creatinine
and to 2m, and the FDm calculation serves to estimate the
degree to which 132m levels are reduced in distal cyst fluid in
comparison to proximal cyst fluid and to serum. In the six
hemodialysis patients, the mean FDm in the distal cysts was
0,039 0.018, with a range of 0 to 0.095.
Cyst /32m levels in post-transplant patients
The availability of polycystic kidneys from two ADPKD
subjects several weeks after a successful kidney transplant
provided the opportunity to determine the extent to which /32m,
creatinine and urea equilibrated between cyst fluid and serum
(Table 2, Fig. 5). Proximal fluid samples were available in both
cases, and though we did not have a serum sample for /32m
analysis from A.B. at the time of nephrectomy (this sample was
lost after the initial analysis), we obtained a sample several
years later when the serum creatinine level was unchanged from
the pre-nephrectomy value. Post-nephrectomy serum creati-
nine and urea nitrogen levels had been measured previously in
A.B. Since in dialysis patients the proximal cyst fluid to serum
ratios of f32m, creatinine and urea nitrogen were virtually unity,
the pre-transpiant serum levels of /32m, creatinine and urea
nitrogen gave an estimate of the proximal cyst fluid levels
expected in each patient prior to renal transplantation. If, after
transplantation, the cyst fluid /32m, creatinine and urea nitrogen
levels completely equilibrated with serum (plasma) values, one
would expect the post-transplant cyst fluid/post-transplant se-
rum ratios to approach unity. In fact, we observed equilibration
of urea nitrogen and creatinine in five proximal cysts from each
subject; however, the 132m levels were distinctly greater than
one in the same proximal cyst fluids (Fig. 5). This analysis
shows that the f32m levels of proximal cysts decreased from the
0(10.7) 0
0
0 0
0 .
'C
.
•
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A.B. M.GJ A.B. M.G. fAA. MG.!
Fig. 5. Equilibration of urea nitrogen, creatinine and 132m in proximal
cysts. Initials refer to patients. Open circles (0) show values for
pre-transplant serum/post-transplant serum for each solute, an estimate
of the relative concentrations of the substances in proximal cyst fluid
prior to renal transplantation. Solid circles (•) show values for post-
transplant cyst fluid/post-transplant serum for each solute. The dashed
horizontal line defines equilibration between cyst fluid and serum.
Values of creatinine and urea nitrogen were not different from unity for
both patients. Values for J32m in post-transplant cyst fluids were
significantly different from unity (A 1.14 0.13 and 0.92 0.22, P <
0.01), and also differed from the estimated pre-transplant cyst fluid
levels (A 4.11 0.13 and 1.67 0.23, P < 0.01).
estimated pre-transplant values in the two patients, although
they did not equilibrate completely with the serum values. The
same type of analysis could not be done for f32m permeability of
distal cysts as we could not estimate the initial azotemic
condition as we did for proximal cysts. It is important to note,
however, that the distal cyst f32m levels in patient A.B. (Table
2) remained below serum levels and appreciably greater than
zero, consistent with low permeability of the cyst wall to /32m.
Discussion
Previous studies indicate that cysts in ADPKD are derived
from tubular segments and continue to function to a variable
extent throughout the life of the patient [1, 4, 6—8, 10, 18]. The
high concentrations of creatinine in distal cysts indicate that the
fluid within them is derived in part from glomerular filtrate.
Since f32m is not actively secreted by proximal or distal tubules
[11, 19—21], the f32m in cysts may have been carried there in
glomerular filtrate or may have diffused into the cysts from the
interstitium. Proximal cysts are undoubtedly permeable to f32m
since the protein partially equilibrated across cyst walls in two
patients after the extracellular fluid composition was normal-
ized by cadaveric renal transplantation (Fig. 5). Filling of the
cysts with non-azotemic glomerular filtrate does not explain the
fall of the f.32m levels in the proximal cysts after successful
transplantation, since one would expect the 2m levels to
equilibrate as did creatinine and urea, and this was not ob-
served. It is also clear that the walls of the proximal cysts are
only sparingly permeable to /32m since they did not completely
equilibrate with plasma, despite contact times of six and 12
weeks. Thus, the current study is consistent with the view that
/32m can diffuse relatively slowly across cyst epithelium down a
concentration gradient and that the f32m in proximal cysts
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derives in part from the diffusion of interstitial f32m into the
cysts. Consequently, the protein can not be considered to be a
unique marker to indicate that glomerular filtrate fills cysts of
proximal origin.
By contrast, distal cyst epithelium is virtually impermeable to
/32m, since some cysts can maintain vanishingly low levels of
f32m despite serum levels exceeding 10,000 Lg/liter. The source
of /32m in these distal segments may be the glomerular filtrate or
fluid delivered from /32m-rich afferent proximal cysts with
tubule connections in series with the distal cysts. The latter
explanation seems unlikely since one cannot account for the
observation that about one—half of the distal cysts have no
detectable /32m in the fluid when, in fact, proximal cysts afferent
to the distal cysts would be expected to discharge high levels of
f32m into distal tubule fluid. One might suppose that distal cysts
with detectable 132m in the fluid are connected to afferent
proximal cysts, but this seems unlikely as the highest FDjm in
distal cysts was 0.19, and the mean FDp2m of proximal cysts was
0.985. For a proximal to distal cyst ratio of 4:1 [9] in the
simplest case of equal flow rates in all cystic and non-cystic
segments, one would expect a FD2m of 0.25, and the average
value is considerably below this. The most economical expla-
nation for the low /32m levels in distal cysts is to suppose that
132m is filtered by the glomeruli and that the protein is reab-
sorbed by proximal tubules. Thus, the levels of creatinine
higher than in serum [91 and the /32m levels in distal cyst fluids
lower than in proximal cyst fluid or serum are consistent with
the view that the fluid in distal cysts is derived in part from
glomerular filtrate. Recent studies (Grantham, J., unpublished
studies) indicate that a significant fraction of the cysts may not
be connected to afferent tubule segments. This may account for
the finding that some of the distal cysts contain no detectable
f32m, and in some the creatinine level is not higher than in
plasma.
Normal proximal tubules reabsorb nearly all of the filtered
f3m [11]. The observation that /32m levels in proximal cysts are
approximately equal to serum values indicates that the abnor-
mal epithelium cannot generate or maintain a gradient for this
protein, despite contact between fluid and epithelium much
longer than in normal proximal tubules. The study of cyst f32m
levels following renal transplantation indicates that the proxi-
mal cyst epithelial permeability to f32m is relatively low, but
despite this the /32m absorptive mechanism is inadequate to
generate or maintain a gradient, whereas distal cysts, which are
derived from tubule segments that do not ordinarily reabsorb
132m, maintain steep gradients for long periods of time. Electron
microscopy studies reveal that most proximal cysts do not have
apical brush borders, but that the junctional complexes of
proximal and distal cysts are identical to those of proximal and
distal tubules [7]. As protein and polypeptide absorption in
proximal tubules depends on endocytic processes in the apical
membranes [11], the absence of brush borders may reflect a
more generalized functional abnormality in the apical surface of
proximal cyst epithelium. The current data also suggest that the
intercellular junctional complexes of proximal cysts are perme-
able to f32m, and that distal cyst junctions are impermeable to
the protein.
The inability of individual cystic proximal tubules to develop
or maintain an transepithelial J32m gradient is not reflected in the
final urine of non-azotemic ADPKD subjects, despite the
marked anatomic renal distortion in these patients revealed by
computed tomography [2]. In these patients the FEp2m was
indistinguishably different from normal. This finding indicates
strongly that the process that causes impaired reabsorption of
f32m in cystic proximal tubules does not affect the non-cystic
tubules. In other words, this functional information indicates
that cyst formation, at least in non-azotemic patients, is a highly
focal process.
Since most proximal cysts with patent efferent tubule con-
nections probably discharge high concentrations of /32m into the
distal tubules, one can infer from the data in Table 1 and Figure
3 that only a small proportion of the proximal tubules in the
non-azotemic subjects contain one or more cysts, otherwise the
fractional excretion of 2m in final urine would be much higher
than normal. The exact proportion of proximal tubules that are
cystic cannot be adduced from the current studies, but it
appears that in non-azotemic patients only a few percent of the
nephrons contributing to the final urine may contain proximal
cysts. As the disease progresses, either more nephrons are
recruited to form cysts, or the function of the non-cystic
nephrons is compromised to account for the rise in FEm and
serum f32m levels. The level of f32m in serum is increased in all
renal diseases when glomerular filtration rate is decreased [23,
24]. In diseased kidneys, a reduction in the filtered load of f32m
apparently leads to an increased concentration of the protein in
serum due to the limited capacity of residual proximal tubules
to absorb and degrade it [6]. We cannot differentiate between
cystic recruitment of additional nephrons or saturation of the
/32m reabsorption mechanism in end—stage kidneys on the basis
of current data, but in view of the observation that ADPKD
progresses to renal insufficiency over a relatively rapid course
in many adult patients [2, 25] without an accelerated increase in
kidney size, it seems more likely that the obliteration of non-
cystic nephrons leading to plasma accumulation is a principle
factor in the abnormal excretion of /32m rather than the forma-
tion of new cysts.
In summary, the studies of thm excretion in urine and
accumulation in renal cysts strengthens the view that cysts
derive from nephron segments, but that cystic proximal tubule
epithelium is unable to maintain concentration gradients of the
protein between cyst fluid and plasma. The overall renal han-
dling of 132m is not unusual in non-azotemic ADPKD patients,
suggesting that the marked anatomic distortion of the paren-
chyma due to the cysts does not alter the tubular processing of
f32m in contiguous normal proximal tubules. Finally, we have
interpreted the results to indicate that the massive size of
polycystic kidneys is due to the remarkable enlargement of a
relatively small number of nephrons.
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